Mutations in IFT172 cause isolated retinal degeneration and Bardet–Biedl syndrome
Kinga M. Bujakowska(Massachusetts Eye and Ear Infirmary), Eric A. Pierce(Broad Institute), L. Ingeborgh van den Born(Rotterdam Eye Hospital), Isabelle Audo(Inserm), Xiaowu Gai(Massachusetts Eye and Ear Infirmary), Bart P. Leroy(Ghent University Hospital), Mark Consugar(Massachusetts Eye and Ear Infirmary), Marni J. Falk(Children's Hospital of Philadelphia), Rob W.J. Collin(Radboud University Nijmegen), José‐Alain Sahel(University of Pittsburgh), Christine Lonjou(Inserm), Christina Zeitz(Centre National de la Recherche Scientifique), Saddek Mohand‐Saïd(Institut de la Vision), Frans P.M. Cremers(Radboud University Nijmegen), Emily Place(MACOM (United States)), Qi Zhang(Qinghai Institute for Endemic Diease Prevention and Control), Qin Liu(Massachusetts Eye and Ear Infirmary), Anneke I. den Hollander(Radboud University Nijmegen), Anna M. Siemiatkowska, Wassila Carpentier(MACOM (United States)), Aline Antonio(Centre National de la Recherche Scientifique), Marie‐Elise Lancelot(Centre National de la Recherche Scientifique)
Cited by 160
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|864
Seven new loci associated with age-related macular degeneration
|Nature Genetics|2013|802